$ News

Assessing Verona Pharma (VRNA) Valuation After Recent Shareholder Returns and Business Momentum

Here’s What Lifted Verona Pharma (VRNA) in Q2

Verona Pharma (VRNA) Rebounded from Challenging Q1

Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025

Does Verona Pharma's Recent FDA Approval Rally Signal Further Upside in 2025?

Here’s What Boosted Verona Pharma plc (VRNA) Share Price by 49%

All You Need to Know About Verona Pharma (VRNA) Rating Upgrade to Buy

Verona Pharma plc (VRNA) Is Unlikely To Face Antitrust Action For Merck Deal, Says Jim Cramer

What Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now?

Verona Pharma plc (VRNA): A Bull Case Theory

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

Verona Pharma (VRNA) Skyrockets 20.6% on $10-Billion Merger Deal with Merck

Piper Sandler Lifts PT on Verona Pharma (VRNA) Stock, Maintains Overweight

Merck will have 'a lot more work to do' after Verona deal

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

Market Minute 7-9-25- Tariff News Rocks Copper, While Fed Chatter Heats Up

Merck Strikes $10 Billion Deal to Buy Verona Pharma

Merck Buys Verona Pharma: A Good Deal, But M&A Spree Must Continue

Trump's tariffs target copper, pharma, Merck to acquire Verona: 3 Things

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade